garenoxacin has been researched along with disopyramide in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (disopyramide) | Trials (disopyramide) | Recent Studies (post-2010) (disopyramide) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 1,659 | 206 | 64 |
| Protein | Taxonomy | garenoxacin (IC50) | disopyramide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, R; Imai, H; Kawai, H; Kitagawa, W; Miura, N; Miyamoto, K; Nishikawa, K; Suga, N; Suzuki, K; Watanabe, H | 1 |
1 other study(ies) available for garenoxacin and disopyramide
| Article | Year |
|---|---|
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Cytochrome P-450 CYP3A; Disopyramide; Fluoroquinolones; Glycyrrhiza; Humans; Hypokalemia; Male; Torsades de Pointes | 2010 |